PRVA Insider Trading

Insider Ownership Percentage: 14.20%
Insider Buying (Last 12 Months): $4,745,481.05
Insider Selling (Last 12 Months): $3,397,826.57

Privia Health Group Insider Trading History Chart

This chart shows the insider buying and selling history at Privia Health Group by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$400M-$200M$0$200M$400MTotal Insider BuyingTotal Insider Selling

Privia Health Group Share Price & Price History

Current Price: $22.75
Price Change: Price Decrease of -1.17 (-4.89%)
As of 03/25/2025 05:00 PM ET

This chart shows the closing price history over time for PRVA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$22.75Closing price on 03/25/25:

SEC Filings (Institutional Ownership Changes) for Privia Health Group (NASDAQ:PRVA)

94.48% of Privia Health Group stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PRVA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$119Mbought$147MsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$200M$0$200MTotal InflowsTotal Outflows
Privia Health Group logo
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.
Read More on Privia Health Group

Today's Range

Now: $22.75
Low: $22.51
High: $24.19

50 Day Range

MA: $23.75
Low: $21.57
High: $25.69

52 Week Range

Now: $22.75
Low: $15.92
High: $26.04

Volume

1,120,538 shs

Average Volume

756,060 shs

Market Capitalization

$2.74 billion

P/E Ratio

227.52

Dividend Yield

N/A

Beta

0.85

Who are the company insiders with the largest holdings of Privia Health Group?

Privia Health Group's top insider shareholders include:
  1. Adam Boehler (Director)
  2. William M Sullivan (Director)
  3. David Mountcastle (CFO)
  4. Parth Mehrotra (CEO)
  5. Parth Mehrotra (COO)
  6. Matthew Shawn Morris (CEO)
  7. Advisors LLC Mbd (Major Shareholder)
  8. Thomas Bartrum (EVP)
  9. Matthew Shawn Morris (Director)
  10. Thomas A Mccarthy (Director)
Learn More about top insider investors at Privia Health Group.

Who are the major institutional investors of Privia Health Group?

Privia Health Group's top institutional investors include:
  1. FMR LLC — 15.17%
  2. Durable Capital Partners LP — 9.57%
  3. Vanguard Group Inc. — 9.52%
  4. Riverbridge Partners LLC — 4.85%
  5. T. Rowe Price Investment Management Inc. — 3.15%
  6. Principal Financial Group Inc. — 2.56%
Learn More about top institutional investors of Privia Health Group stock.

Which institutional investors are selling Privia Health Group stock?

In the last quarter, PRVA stock was sold by these institutional investors:
  1. T. Rowe Price Investment Management Inc.
  2. Wellington Management Group LLP
  3. Wellington Management Group LLP
  4. Vanguard Group Inc.
  5. Bank of New York Mellon Corp
  6. Principal Financial Group Inc.
  7. Bellevue Group AG
  8. ExodusPoint Capital Management LP
During the previous year, company insiders that have sold Privia Health Group company stock include:
  1. Adam Boehler (Director)
  2. William M Sullivan (Director)
  3. David Mountcastle (CFO)
  4. Parth Mehrotra (CEO)
Learn More investors selling Privia Health Group stock.

Which institutional investors are buying Privia Health Group stock?

In the previous quarter, PRVA stock was purchased by institutional investors including:
  1. Riverbridge Partners LLC
  2. Loomis Sayles & Co. L P
  3. Durable Capital Partners LP
  4. BlackBarn Capital Partners LP
  5. Nuveen Asset Management LLC
  6. BNP Paribas Financial Markets
  7. JPMorgan Chase & Co.
  8. Marshall Wace LLP
During the previous year, these company insiders have bought Privia Health Group stock:
  1. Adam Boehler (Director)
  2. William M Sullivan (Director)
Learn More investors buying Privia Health Group stock.